Expression of the ERBB3 Gene Product in Breast Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 1992 Dec 1

PMID 1333787

Citations 72

Authors

N R Lemoine

D M Barnes

D P Hollywood

C M Hughes

P Smith

E Dublin

S A Prigent

W J Gullick

H C Hurst

Affiliations

Soon will be listed here.

Abstract

Abnormalities of the EGF receptor and/or the related ERBB2 receptor occur in a significant proportion of cases of human breast cancer and are important influences in the behaviour of this tumour type. In this report we demonstrate by nucleic acid analysis and immunohistochemistry that the recently recognised third member of this gene family, ERBB3, shows a wide range of expression in breast cancer, and shows stronger immunoreactivity than that observed in normal tissue in 43 out of 195 cases (22%) of primary breast cancer. Overexpression of ERBB3 appears to result from increased levels of gene transcription since in none of the cell lines or primary cancers analysed did we find evidence of gene amplification. High expression of ERBB3 is positively associated with the presence of lymph node metastases, but there was no demonstrable relationship with patient survival in this series.

Citing Articles

Busting the Breast Cancer with AstraZeneca's Gefitinib.

Chemmalar S, Intan Shameha A, Abdullah C, Ab Razak N, Mohamad Yusof L, Ajat M Adv Pharmacol Pharm Sci. 2023; 2023:8127695.

PMID: 38090376 PMC: 10713255. DOI: 10.1155/2023/8127695.

HER3: Toward the Prognostic Significance, Therapeutic Potential, Current Challenges, and Future Therapeutics in Different Types of Cancer.

Majumder A Cells. 2023; 12(21).

PMID: 37947595 PMC: 10648638. DOI: 10.3390/cells12212517.

Detection of HER-3 with an AlGaN/GaN-Based Ion-Sensitive Heterostructure Field Effect Transistor Biosensor.

Wang F, Liu H, Xu Y, Liang Z, Wu Z, Liu Y Micromachines (Basel). 2023; 14(6).

PMID: 37374771 PMC: 10301427. DOI: 10.3390/mi14061186.

Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1.

Cruz R, Madden S, Richards C, Vellanki S, Jahns H, Hudson L Cancers (Basel). 2021; 13(4).

PMID: 33669586 PMC: 7922773. DOI: 10.3390/cancers13040871.

miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop.

Liu D, Lu L, Dong L, Liu Y, Bian X, Lian B Theranostics. 2020; 10(8):3668-3683.

PMID: 32206115 PMC: 7069088. DOI: 10.7150/thno.41365.

References

Peto R, Pike M, Armitage P, Breslow N, Cox D, Howard S . Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977; 35(1):1-39. PMC: 2025310. DOI: 10.1038/bjc.1977.1. View

Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785):177-82. DOI: 10.1126/science.3798106. View

Kumar R, Shepard H, Mendelsohn J . Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells. Mol Cell Biol. 1991; 11(2):979-86. PMC: 359762. DOI: 10.1128/mcb.11.2.979-986.1991. View

Gullick W, Love S, Wright C, Barnes D, Gusterson B, Harris A . c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br J Cancer. 1991; 63(3):434-8. PMC: 1971853. DOI: 10.1038/bjc.1991.100. View

Gullick W, Hughes C, Mellon K, Neal D, Lemoine N . Immunohistochemical detection of the epidermal growth factor receptor in paraffin-embedded human tissues. J Pathol. 1991; 164(4):285-9. DOI: 10.1002/path.1711640403. View

Gullick W . The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancer. Int J Cancer Suppl. 1990; 5:55-61. DOI: 10.1002/ijc.2910460708. View

Plowman G, Whitney G, Neubauer M, Green J, McDonald V, Todaro G . Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci U S A. 1990; 87(13):4905-9. PMC: 54229. DOI: 10.1073/pnas.87.13.4905. View

Sainsbury J, Farndon J, Needham G, Malcolm A, Harris A . Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987; 1(8547):1398-402. DOI: 10.1016/s0140-6736(87)90593-9. View

Costa S, Stamm H, Almendral A, Ludwig H, Wyss R, Fabbro D . Predictive value of EGF receptor in breast cancer. Lancet. 1988; 2(8622):1258. DOI: 10.1016/s0140-6736(88)90856-2. View

10.

Gullick W, Downward J, Foulkes J, Waterfield M . Antibodies to the ATP-binding site of the human epidermal growth factor (EGF) receptor as specific inhibitors of EGF-stimulated protein-tyrosine kinase activity. Eur J Biochem. 1986; 158(2):245-53. DOI: 10.1111/j.1432-1033.1986.tb09744.x. View

11.

Cleveland D, Lopata M, MacDonald R, Cowan N, Rutter W, Kirschner M . Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell. 1980; 20(1):95-105. DOI: 10.1016/0092-8674(80)90238-x. View

12.

HAYWARD J, Meakin J, Stewart H . Assessment of response and recurrence in breast cancer. Semin Oncol. 1978; 5(4):445-9. View

13.

Perren T . c-erbB-2 oncogene as a prognostic marker in breast cancer. Br J Cancer. 1991; 63(3):328-32. PMC: 1971858. DOI: 10.1038/bjc.1991.78. View

14.

Shepard H, Lewis G, Sarup J, Fendly B, Maneval D, Mordenti J . Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic. J Clin Immunol. 1991; 11(3):117-27. DOI: 10.1007/BF00918679. View

15.

Bartek J, Bartkova J, Kyprianou N, Lalani E, Staskova Z, Shearer M . Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci U S A. 1991; 88(9):3520-4. PMC: 51483. DOI: 10.1073/pnas.88.9.3520. View

16.

Kraus M, Issing W, Miki T, Popescu N, Aaronson S . Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A. 1989; 86(23):9193-7. PMC: 298460. DOI: 10.1073/pnas.86.23.9193. View

17.

Venter D, Tuzi N, Kumar S, Gullick W . Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistological assessment correlates with gene amplification. Lancet. 1987; 2(8550):69-72. DOI: 10.1016/s0140-6736(87)92736-x. View

18.

Midgley C, Fisher C, Bartek J, Vojtesek B, Lane D, Barnes D . Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci. 1992; 101 ( Pt 1):183-9. DOI: 10.1242/jcs.101.1.183. View